Study of Endostatin Combined With Docetaxel in the Treatment of Advanced Non-small Cell Lung Cancer Patients
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to examine the efficacy and safety of endostatin combined with
Docetaxel in advanced Non-Small-Cell Lung Carcinoma (NSCLC) patients failure to first-line or
second-line chemotherapy.